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Abstract
Randomised trials with continuous outcomes are often analysed using ANCOVA,
with adjustment for prognostic baseline covariates. In an article published recently,
Wang et al proved that in this setting the model based standard error estimator for
the treamtent effect is consistent under outcome model misspecification, provided the
probability of randomisation to each treatment is 1/2. In this article, we extend their
results allowing for unequal randomisation. These demonstrate that the model based
standard error is in general inconsistent when the randomisation probability differs
from 1/2. In contrast, the sandwich standard error can provide asymptotically valid
inferences under misspecification when randomisation probabilities are not equal, and
is therefore recommended when randomisation is unequal.
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1 Introduction
In randomised trials with continuous outcomes the baseline covariate adjusted treat-
ment effect estimator is consistent even if the assumed linear regression model (AN-
COVA) is misspecified [4]. Recently Wang et al proved that under certain conditions,
the model based variance estimator from an ANCOVA analysis of a randomised trial
is valid under arbitrary misspecification, and therefore advocated its use for analysis
of trials with continuous outcomes [3]. Concurrently, the US FDA have recently issued
draft guidance on the topic of baseline covariate adjustment in randomised trials with
continuous outcomes [1]. This draft guidance also advocates use of ANCOVA, and
states that the type I error rate is controlled even when the model is misspecified.
An assumption used by Wang et al is that the probabilities of randomisation to the
two arms are equal [3]. While this is commonly the case in randomised trials, many
trials are conducted with unequal randomisation probabilities. In particular often the
probability of randomisation to the experimental arm is greater than 1/2 in light of a
hoped for improved outcome on the experimental treatment compared to control. In
this article we explore the impact of violations of the equal randomisation probability
assumption on the validity of the model based ANCOVA standard error, and thereby
the impact on type I error and confidence interval coverage.
2 Model based ANCOVA variance estimation
with unequal randomisation
Following the notation of Wang et al , we assume we observe n i.i.d. copies of (W, A, Y ),
where W is a k × 1 column vector of bounded baseline covariates, A is the binary
treatment group indicator (A = 1 for experimental treatment, A = 0 for control)
and Y is the continuous outcome. Like Wang et al , we assume A ⊥⊥ W , but we let
P (A = 1) = pi, where pi may differ from 1/2.
The target of inference is the average treatment effect ∆ = E(Y |A = 1)−E(Y |A =
2
0). The unadjusted estimator of ∆ is the difference in treatment group sample means:
∆ˆunadj =
∑n
i=1 YiAi/
∑n
i=1Ai −
∑n
i=1 Yi(1 − Ai)/
∑n
i=1(1 − Ai). The ANCOVA esti-
mator adjusts for the baseline covariates W by fitting the following linear regression
model:
E(Y |A,W) = β0 + βAA+ β
T
WW (1)
where the regression coefficients are estimated by the ordinary least square estimators
βˆ0, βˆA, and βˆW. The ANCOVA estimator ∆ˆ
ancova of ∆ is ∆ˆancova = βˆA. We let β
0
,
β
A
and β
W
denote the probability limits of these estimators.
As noted by Wang et al , Yang & Tsiatis [4] and Tsiatis et al [2] proved, under
the stated assumptions, that ∆ˆancova is a consistent estimator of ∆ under arbitrary
misspecification of the linear model in equation (1), so that β
A
= ∆. Following Wang
et al , we let V ar∗(∆ˆancova) denote the asymptotic variance of ∆ˆancova, in the sense
that n1/2(∆ˆancova −∆) converges in distribution to a mean zero normal with variance
V ar∗(∆ˆancova).
Inferences from ANCOVA are by default in statistical software packages based on
the so called model based variance estimator for ∆ˆancova, which is given by
V̂ ar(∆ˆancova) =
V̂ ar(Y − βˆ0 − βˆAA− βˆ
T
W
W)
(n− 1)
[
V̂ ar(A)− Ĉov(W, A)T V̂ ar(W)−1Ĉov(W, A)
]
where following Wang et al the estimated variances and covariances on the right hand
side are sample variance and sample covariances, with degrees of freedom taken into
account (see the Supporting Information of Wang et al [3] for precise definitions).
Wang et al prove that when pi = 1/2, nV̂ ar(∆ˆancova) converges in probability to the
true asymptotic variance V ar∗(∆ˆancova). As a consequence, under these assumptions,
asymptotically Wald-type hypothesis tests have the correct type I error under the null
∆ = 0 and the corresponding confidence intervals attain their nominal coverage levels.
The following theorem, proved in the Supporting Information, gives the asymptotic
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variance of ∆ˆancova for arbitrary 0 < pi < 1, generalising the results of Wang et al .
Theorem 1 Given the previously stated assumptions with 0 < pi < 1, the true asymp-
totic variance V ar∗(∆ˆancova) of the ANCOVA estimator ∆ˆancova is given by
V ar∗(∆ˆancova) =
V ar(Y − βT
W
W|A = 1)
pi
+
V ar(Y − βT
W
W|A = 0)
1− pi
The next theorem, again proved in the Supporting Information,, gives the proba-
bility limit of nV̂ ar(∆ˆancova) under arbitrary 0 < pi < 1.
Theorem 2 For the model based variance estimator V̂ ar(∆ˆancova) we have
nV̂ ar(∆ˆancova)
P
−→
V ar(Y − βT
W
W|A = 1)
1− pi
+
V ar(Y − βT
W
W|A = 0)
pi
Together the two theorems imply that the model based variance estimator of ∆ˆancova
is only asymptotically valid (and hence hypothesis tests and confidence intervals have
correct asymptotic size and coverage) if pi = 1/2, as assumed by Wang et al , or
if V ar(Y − βT
W
W|A = 1) = V ar(Y − βT
W
W|A = 0). When pi 6= 1/2, the latter
conditional variances are not in general equal under misspecification of the outcome
model. For example, even if the conditional mean function E(Y |A,W) is correctly
specified, if the conditional variance of Y given W in the two treatment groups dif-
fer, the model based ANCOVA variance estimator is biased. Alternatively, even if
V ar(Y |A = 1) = V ar(Y |A = 0), if Cov(Y, βT
W
W|A = 1) 6= Cov(Y, βT
W
W|A = 0), the
model based ANCOVA variance estimator is again biased. This would in general occur
if the outcome had the same variance in the two treatment groups, but the covariates
W were prognostic for Y to different extents in the two treatment groups.
We note that a special case of our result occurs when W is empty, such that
∆ˆancova = ∆ˆunadj . In this case our result corresponds to the well known fact that
the two sample t-test does not control the type I error rate in general if the outcome
variable has different variance in the two groups, which leads to Welch’s adaptation of
the t-test allowing for unequal variances.
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Our results imply that when pi 6= 1/2, the model based ANCOVA variance estimator
could be biased downwards or upwards, depending on the configuration, leading to a
type I error rate either below or above the nominal level. Suppose for example that
pi > 1/2, such that a greater proportion of patients are randomised to the experimental
treatment. Then if V ar(Y −βT
W
W|A = 1) > V ar(Y −βT
W
W|A = 0) the model based
ANCOVA variance is too large, leading to type I error rates lower than the nominal
level, whereas if V ar(Y − βT
W
W|A = 1) < V ar(Y − βT
W
W|A = 0) the model based
ANCOVA variance is too small, leading to inflated type I error rates.
3 Discussion
We have shown that the model based ANCOVA variance estimator of the average
treatment effect is under general misspecification of the outcome model inconsistent
when pi 6= 0.5. In trials with unequal randomisation this variance estimator cannot
therefore be recommended for general use. Instead, the sandwich variance estimator,
as described by Tsiatis et al [2], provides asymptotically valid inferences for any ran-
domisation probability under arbitrary misspecification. An important exception is if
randomisation is not simple, as was assumed here and in Wang et al [3]. For example,
as noted by Wang et al , under stratified randomisation schemes, obtaining asymptoti-
cally valid standard errors when covariates not used in the randomisation are adjusted
for, under general misspecification of the outcome model, remains an open problem.
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Supporting Information
We prove Theorems 1 and 2 of the main paper, referring frequently to the supporting
information of Wang et al [3].
Proof of Theorem 1
Following the proof of Theorem B.2 of Wang et al , the estimating function correspond-
ing to the ANCOVA regression is given by
ψβ(Y,A,W) = (Y − β0 − βAA− β
T
WW)

1
A
W

Then as noted by Wang et al , the OLS estimators βˆ = (βˆ0, βˆA, βˆ
T
W
) are the solutions
to the estimating equation
∑n
i=1 ψβˆ(Y,A,W) = 0 and its probability limit β satisfies
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E(ψβ(Y,A,W)) = 0. The influence function of βˆ is
IFβˆ(Y,A,W ) = −
[
E
(
∂ψβ(Y,A,W )
∂βT
)]
−1
ψβ(Y,A,W )
After some matrix algebra, and using the fact that A ⊥⊥ W , one can show that the
influence function of ∆ˆancova is
IFancova(Y,A,W ) =
A− pi
pi(1− pi)
(Y − β
0
− β
A
A− βT
W
W)
Note that when pi = 1/2, this reduces to the corresponding expression given by Wang
et al . The asymptotic variance of the estimator ∆ˆancova is then given by the variance
of this influence function. Since influence functions have mean zero, this variance is
given by
V ar(IFancova(Y,A,W )) = E
[
(A− pi)2
pi2(1− pi)2
(Y − β
0
− β
A
A− βT
W
W)2
]
Then using the fact thatE(ψβ(Y,A,W)) = 0, we have that E
(
Y − β
0
− β
A
A− βT
W
W
)
=
0, and thus that
V ar(IFancova(Y,A,W )) =
1
pi2(1− pi)2
[
pi(1− pi)2V ar(Y − β
0
− β
A
A− βT
W
W|A = 1)
+(1− pi)pi2V ar(Y − β
0
− β
A
A− βT
W
W|A = 0)
]
=
1
pi2(1− pi)2
[
pi(1− pi)2V ar(Y − βT
W
W|A = 1)
+(1− pi)pi2V ar(Y − βT
W
W|A = 0)
]
=
V ar(Y − βT
W
W|A = 1)
pi
+
V ar(Y − βT
W
W|A = 0)
1− pi
as required.
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Proof of Theorem 2
Theorem B.3 of Wang et al argues why V̂ ar(Y −βˆ0−βˆAA−βˆ
T
W
W)
P
−→ V ar(Y −β
A
A−
βT
W
W), and their argument applies for any 0 < pi < 1. Next, we have that n/(n−1)→
1, V̂ ar(A)
P
−→ V ar(A) = pi(1 − pi), by independence of A and W Ĉov(W, A)
P
−→
Cov(W, A) = 0, and V̂ ar(W)
P
−→ V ar(W). Then from the definition of V̂ ar(∆ˆancova)
it follows that
nV̂ ar(∆ˆancova)
P
−→
V ar(Y − β
A
A− βT
W
W)
pi(1− pi)
Next, we write the variance in the numerator as
V ar(Y − β
A
A− βT
W
W) = V ar(E(Y − β
A
A− βT
W
W|A)) + E(V ar(Y − β
A
A− βT
W
W|A))
The second of these terms can be expressed as
E(V ar(Y − β
A
A− βT
W
W|A)) = piV ar(Y − β
A
A− βT
W
W|A = 1)
+(1− pi)V ar(Y − β
A
A− βT
W
W|A = 0)
= piV ar(Y − βT
W
W|A = 1) + (1− pi)V ar(Y − βT
W
W|A = 0)
Next, the fact that E(ψβ(Y,A,W)) = 0 implies
E
[
(Y − β
0
− β
A
A− βT
W
W)A
]
= 0
which in turn implies
piE
[
Y − β
0
− β
A
A− βT
W
W|A = 1
]
= 0
Then the fact that E
(
Y − β
0
− β
A
A− βT
W
W
)
= 0 means that
piE(Y − β
0
− β
A
A− βT
W
W|A = 1) + (1− pi)E(Y − β
0
− β
A
A− βT
W
W|A = 0) = 0
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and since piE
[
Y − β
0
− β
A
A− βT
W
W|A = 1
]
= 0, we have that
E
[
Y − β
0
− β
A
A− βT
W
W|A = 0
]
= 0
Thus we have shown that
V ar(E(Y − β
0
− β
A
A− βT
W
W|A)) = 0
and therefore also that
V ar(E(Y − β
A
A− βT
W
W|A)) = V ar(β
0
+ E(Y − β
0
− β
A
A− βT
W
W|A))
= V ar(E(Y − β
0
− β
A
A− βT
W
W|A))
= 0
We have thus shown
V ar(Y − β
A
A− βT
W
W) = piV ar(Y − βT
W
W|A = 1) + (1− pi)V ar(Y − βT
W
W|A = 0)
and so
nV̂ ar(∆ˆancova)
P
−→
piV ar(Y − βT
W
W|A = 1) + (1− pi)V ar(Y − βT
W
W|A = 0))
pi(1− pi)
=
V ar(Y − βT
W
W|A = 1)
1− pi
+
V ar(Y − βT
W
W|A = 0)
pi
as was required to be shown.
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